Log in

Xenetic Biosciences Stock Price, News & Analysis (NASDAQ:XBIO)

$1.24
-0.11 (-8.15 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$1.22
Now: $1.24
$1.46
50-Day Range
$1.05
MA: $1.36
$1.66
52-Week Range
$0.99
Now: $1.24
$44.40
Volume794,420 shs
Average Volume950,835 shs
Market Capitalization$4.64 million
P/E RatioN/A
Dividend YieldN/A
Beta2.47
Xenetic Biosciences, Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:XBIO
CUSIPN/A
CIKN/A
Phone781-778-7720

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.59 million
Book Value$12.65 per share

Profitability

Net Income$-7,300,000.00

Miscellaneous

Employees4
Market Cap$4.64 million
Next Earnings Date11/8/2019 (Estimated)
OptionableNot Optionable

Receive XBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for XBIO and its competitors with MarketBeat's FREE daily newsletter.


Xenetic Biosciences (NASDAQ:XBIO) Frequently Asked Questions

What is Xenetic Biosciences' stock symbol?

Xenetic Biosciences trades on the NASDAQ under the ticker symbol "XBIO."

How were Xenetic Biosciences' earnings last quarter?

Xenetic Biosciences Inc (NASDAQ:XBIO) announced its quarterly earnings data on Thursday, August, 15th. The company reported ($1.56) earnings per share for the quarter. View Xenetic Biosciences' Earnings History.

When is Xenetic Biosciences' next earnings date?

Xenetic Biosciences is scheduled to release their next quarterly earnings announcement on Friday, November 8th 2019. View Earnings Estimates for Xenetic Biosciences.

Has Xenetic Biosciences been receiving favorable news coverage?

News headlines about XBIO stock have been trending very negative on Saturday, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Xenetic Biosciences earned a media sentiment score of -3.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Xenetic Biosciences.

Are investors shorting Xenetic Biosciences?

Xenetic Biosciences saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 60,000 shares, an increase of 17.9% from the August 30th total of 50,900 shares. Based on an average trading volume of 386,600 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.5% of the company's stock are sold short. View Xenetic Biosciences' Current Options Chain.

Who are some of Xenetic Biosciences' key competitors?

What other stocks do shareholders of Xenetic Biosciences own?

Who are Xenetic Biosciences' key executives?

Xenetic Biosciences' management team includes the folowing people:
  • Mr. Jeffrey F. Eisenberg, CEO & Director (Age 53)
  • Mr. James F. Parslow, CFO, COO & Corp. Sec. (Age 54)
  • Dr. Curtis A. Lockshin, Chief Scientific Officer (Age 59)

How do I buy shares of Xenetic Biosciences?

Shares of XBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Xenetic Biosciences' stock price today?

One share of XBIO stock can currently be purchased for approximately $1.24.

How big of a company is Xenetic Biosciences?

Xenetic Biosciences has a market capitalization of $4.64 million and generates $7.59 million in revenue each year. Xenetic Biosciences employs 4 workers across the globe.View Additional Information About Xenetic Biosciences.

What is Xenetic Biosciences' official website?

The official website for Xenetic Biosciences is http://www.xeneticbio.com/.

How can I contact Xenetic Biosciences?

Xenetic Biosciences' mailing address is 40 Speen Street Suite 102, Framingham MA, 01701. The company can be reached via phone at 781-778-7720 or via email at [email protected]


MarketBeat Community Rating for Xenetic Biosciences (NASDAQ XBIO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  118 (Vote Underperform)
Total Votes:  254
MarketBeat's community ratings are surveys of what our community members think about Xenetic Biosciences and other stocks. Vote "Outperform" if you believe XBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: P/E Growth (PEG)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel